Loading clinical trials...
Loading clinical trials...
Cutaneous Leishmaniasis in Ethiopia causes severe dermatological mutilations. Forms that require systemic treatment are cLCL, MCL, and DCL. National guidelines recommend equally all drugs that are als...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
NCT03292835 · Cutaneous Leishmaniases
NCT04512742 · Leishmaniasis, Cutaneous Leishmaniases, and more
NCT03837431 · Cutaneous Leishmaniases
NCT04001335 · Cutaneous Leishmaniases
NCT02919605 · Cutaneous Leishmaniases
Boru Meda Hospital
Boru
Gondar University Hospital
Gonder
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions